|4Nov 15, 6:05 AM ET

Booth Andrew 4

4 · AbCellera Biologics Inc. · Filed Nov 15, 2021

Insider Transaction Report

Form 4
Period: 2021-11-11
Booth Andrew
Chief Financial Officer
Transactions
  • Purchase

    Common Shares

    2021-11-11$14.61/sh+14,000$204,540130,959 total(indirect: By Spouse)
  • Purchase

    Common Shares

    2021-11-11$14.74/sh+53,500$788,59053,500 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.60 and $14.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.67 and $14.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION